Home > Financial > Scientific Crusade against Osteoarthritis

Scientific Crusade against Osteoarthritis

Added: (Thu Apr 22 2010)

Pressbox (Press Release) - Mumbai, April 21, 2010:
Exotic Naturals announces the launch of E-OA-07, a Support formula for Osteoarthritis.
A clinically proven safe and effective innovative research formula to sustain healthy joints, promote joint flexibility and mobility and give comfort against stiffness and pain.

Exotic Naturals, CEO, Jayesh Chaudhary stated, “It was noteworthy to see that E-OA-07 was successful in maintaining the positive outcomes even in the withdrawal phase of the study.”

Exotic Naturals’ crusade against OA led to its dedication towards their ‘save your knees’ campaign and the subsequent formulation of E-OA-07. The focus was to develop an herbal supplement with clinically proven efficacy & safety. A Double Blind, Randomized, Placebo controlled Proof of Concept clinical trial was carried out as per ICH-GCP guidelines.

Treatment duration for this trial was for 84 days and thereafter patients were observed for 46 days (Withdrawal Phase). This Study showed a statistically significant (p<0.01) decrease in pain and stiffness as assessed through both WOMAC and VAS and as compared to placebo. The pain relieving efficacy of E-OA-07 was observed as early/ initially as on Day 42, was statistically superior over placebo at Day 84 and remained consistently significant up to the end of withdrawal phase / end of study (Day 130).

We invite marketing channels and distributors to get exclusive rights on this product.

For more information on our Research Program do write to us at bizdev@exoticnatural.com or visit us at http://www.exoticnatural.com/

Now you can meet us at VITAFOODS 2010 at India Pavilion (Stand No 200). To confirm the appointment, kindly mail to marketing@exoticnatural.com

Submitted by:exoticnaturals Find out more.
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.